CHROMID®
Colistin R (COLR)
CHROMID®
CARBA SMART
CHROMID®
CPS® Elite
Contact us

Reveal pathogens! bioMérieux CHROMID® range puts it in living color

Multi-drug resistant organisms (MDRO) and healthcare-associated infections are major patient-care and economic challenges for healthcare systems. CHROMID chromogenic media for simultaneous culture and identification offers easy-to-read results with color intensity and specificity.

 

Detect resistant organisms Urinary tract infections

CHROMID®  Colistin R (COLR)

CHROMID® CARBA SMART

CHROMID® CPS® Elite

 

FIGHT ANTIMICROBIAL RESISTANCE

CHROMID CARBA SMART and the new CHROMID Colistin R (COLR) are part of bioMérieux’s CHROMID MDRO range for the screening of multi-drug resistant organisms.

  • Help ensure patients get the right treatment at the right time.
  • Help fight antimicrobial resistance and sustain antibiotic efficacy for the future.

 

CHROMID® Colistin R (COLR)

Multidrug-resistant Gram-negative bacteria infections are serious and hard to treat. A last-line antibiotic, Colistin might offer a solution… but what about colistin resistance? The new CHROMID Colistin R agar (COLR) can be used for screening colistin-resistant Gram-negative bacteria and for qualitative resistance detection to colistin from isolated colonies.

  • Screening of Enterobacteriaceae colistin-resistant micro-organisms in clinical and veterinary samples: E.coli, K.pneumoniae, Enterobacter spp and Salmonella spp.
  • Results in 18-24 hours after 4-5 hour enrichment*
  • Facilitates identification of colistin-resistance carriers

Get the reading guide now

CHROMID Colistin R: What do the experts say?

“CHROMID Colistin R agar represents a selective and specific method to perform surveillance studies to detect colistin-resistant Enterobacteriaceae using both stool and swabs samples.”

– Garcia-Fernandez, et. al., 2018 (see ref. below)

 

Be sure to also read about other important CHROMID MDRO media plates:

CHROMID® CARBA SMART

Carbapenemase-producing Enterobacteriacae (CPE) are multidrug-resistant bacteria sometimes implicated in healthcare-associated infections (HAI) and even epidemics. Rapid detection of CPE contributes to better infection prevention and control, patient care and epidemiological monitoring. Screen for all CPE in just one step with CHROMID CARBA SMART selective chromogenic media bi-plate.

  • Bi-plate for complete screening:
    • OXA-48 on one side
    • Other CPE, notably KPC and NDM-1, on the other
  • Easy-to-use, single-step process
  • Validated for both rectal swabs and stool specimens*
  • Incubation in 18/24 hours

Get the reading guide now

CHROMID CARBA SMART: What do the experts say?

“When [CHROMID OXA-48 is] used with CHROMID CARBA, this combination of media potentially offers a highly effective solution for detection of Enterobacteriaceae with any commonly encountered carbapenemase.”

– Zarakolu P., et al., 2015 (see ref. below)

 

Be sure to also read about other important

 

URINARY TRACT INFECTIONS

Urinary tract infections (UTIs) are among the most commonly seen infections in the clinical environment. UTIs are involved in up to 40% of healthcare-associated infections (HAI) and are increasingly caused by multidrug-resistant organisms.1

CHROMID® CPS® Elite for urinary tract infections

CHROMID CPS Elite enables the isolation, enumeration and direct or presumptive identification of organism involved in urinary tract infections.

  • Sensitivity of detection and specificity of coloration: Easy reading – even with mixed cultures*
  • Transparent or opaque versions available
  • Incubation: 16/18 hours for E. Coli

Get the reading guide now

CHROMID CPS Elite: What do the experts say?

“CHROMID CPS Elite is accurate for uropathogen identification, reduces consumable usage, and may expedite the identification of E. coli in clinical specimens.”

– Yarbrough, et. al., 2016 (see ref. below)

 

Be sure to also read about other important CHROMID MDRO media plates:

 

1) Brunner & Suddarth’s textbook of medical-surgical nursing (12th ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2010. p. 1359.

GET THE READING GUIDES & MORE INFORMATION ON CHROMID®

Fill out the form below to receive your reading guides and ask for more resources.

In connection with one or more of the purposes outlined above, we may disclose details to bioMérieux group and/or to third parties that provide services to us and/or bioMérieux group. We will hold your personal data on our systems for the longest of the following periods: (i) as long as is necessary for the relevant activity or services; (ii) any retention period that is required by law; (iii) the end of the period in which litigation or investigations might arise in respect of the services unless prior requesting deletion sent to PrivacyOfficer@biomerieux.com.

Please note that, at any time, you can exercise your right to access, to rectify and to erase your personal data. You may also request limitation, portability or to opt out consent from processing, and not to be subject to an automated data processing, by contact our data protection officer at PrivacyOfficer@biomerieux.com.

If you are unhappy with the way we have handled your personal data or any privacy query or request that you have raised with us, you have a right to complain to the EU Data Protection Authority (“DPA”) in your jurisdiction. If you would like to be directed to the appropriate DPA, or if you would like contact us with any questions or concerns about privacy issues or Personal Data management, please contact: PrivacyOfficer@biomerieux.com.

By submitting this form, you agree to the processing of your personal data in accordance with our Privacy Statement.

Related articles

Articles on CHROMID Colistin R agar:

  • Garcia Fernandez, S., Canton, R. et. al. “CHROMID Colistin R agar (COLR), a new chromogenic medium for screening of Gram-negative Enterobacteriacae: performance results from a clinical validation study.” Presented April 23, 2018 at ECCMID 2018.
  • Bala, Y. et. al. “Can CHROMID Colistin R agar (COLR) be used to test colistin susceptibility in Enterobacteriaceae?” Presented April 24, 2018 at ECCMID 2018.
  • Ghirardi, S. et. al. “CHROMID Colistin R agar: compatibility with identification testing products and standard CLSI broth microdilution method.” Poster, ECCMID 2018.

Articles on CHROMID CARBA SMART:

  • Papadimitriou-Olivgeris, M., et al.: “Performance of CHROMID CARBA Medium for Carbapenemases-Producing Enterobacteriaceae Detection during Rectal Screening.” Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):35-40. doi: 10.1007/s10096-013-1925-6
  • Wilkinson, K.M. et al: “A comparison of four chromogenic culture media for carbapenemase-producing Enterobacteriaceae.” J Clin Microbiol. 2012;50:3102-4

Articles on CHROMID CPS Elite:

  • Yarbrough ML, et. al. “Culture of Urine Specimens by Use of CHROMID CPS Elite Medium Can Expedite Escherichia coli Identification and Reduce Hands-On Time in the Clinical Laboratory.” J Clin Microbiol. 2016 Nov;54(11):2767-2773
  • Stefaniuk, E.M.: “The Usefulness of Chromogenic Media for Qualitative and Semi-Quantitative Diagnostic of Urinary Tract Infections.” Pol J Microbiol. 2018 Jun 30;67(2):213-218. doi: 10.21307/pjm-2018-031.
bioMérieux S.A. - 69280 Marcy l'Etoile - France
© BIOMÉRIEUX SA